Charles Albright, EVP/Chief Scientific Officer at Editas Medicine, Inc. (EDIT), sold 10,238 shares at $37.47 ($383K) on 2020-08-06, disclosed to the SEC on 2020-08-10.
Open-market sale of $383k EDIT by EVP/Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.47 | 10,000 | $375K | 97.8% |
| 2 | $34.99 | 238 | $8K | 2.2% |
| Total | $37.41 avg | 10,238 | $383K | 100% |
| Filing → |
| EDIT | SELL | 2020-12-08 | $1.6M | — | Filing → |
| EDIT | SELL | 2020-11-10 | $7K | — | Filing → |
| EDIT | SELL | 2020-10-16 | $94K | — | Filing → |